Reminder: Invitation to Elekta’s year-end report and company update presentation (Cision)
STOCKHOLM, May 29, 2017 – Elekta (EKTA-B.ST) will publish its year-end report on June 1 at 13:00 CET. In conjunction with this, Elekta would like to take the opportunity to invite equity analysts, investors and media representatives to a presentation of the year-end report as well as a company update.
Presentations will start at 15:00 CET and will end at approximately 17:00 CET. Speakers at the event will include Richard Hausmann, Elekta’s President and CEO, Håkan Bergström, Elekta’s CFO, and Ioannis Panagiotelis, Elekta’s Chief Marketing Officer. Gustaf Salford, who will succeed Håkan Bergström as CFO, effective from July 1, 2017, will also be introduced at the event. The presentation will be held at IVA, Grev Turegatan 16, Stockholm. The doors open at 14:30 CET. It will also be possible to follow the presentation over the phone and as a live webcast. Please use the following link for the webcast: http://elekta-live.creo.tv/cmd-2017 or use the telephone numbers below: · Swedish dial-in number: +46 (0)856642508 · UK dial-in number: +44 (0)2030089801 · US dial-in number: +1 6465025118 Please confirm your participation by e-mail to email@example.com. # # # For further information, please contact: Johan Andersson, Director Investor Relations, Elekta AB Tel: +46 702 100 451, e-mail: firstname.lastname@example.org Time zone: CET: Central European Time Tobias Bülow, Director Financial Communications, Elekta AB Tel: +46 722 215 017, e-mail: email@example.com Time zone: CET: Central European Time Frida Johansson, Investor Relations, Elekta AB Tel: +46 708 667 674, e-mail: firstname.lastname@example.org Time zone: CET: Central European Time About Elekta Elekta is proud to be the leading innovator of equipment and software used to improve, prolong and save the lives of people with cancer and brain disorders. Our advanced, effective solutions are created in collaboration with customers, and more than 6,000 hospitals worldwide rely on Elekta technology. Our treatment solutions and oncology informatics portfolios are designed to enhance the delivery of radiation therapy, radiosurgery and brachytherapy, and to drive cost efficiency in clinical workflows. Elekta employs 3,600 people around the world. Headquartered in Stockholm, Sweden, Elekta is listed on NASDAQ Stockholm. www.elekta.com